Compare DLB & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DLB | HSIC |
|---|---|---|
| Founded | 1965 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Medical Specialities |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 8.8B |
| IPO Year | 2005 | 1995 |
| Metric | DLB | HSIC |
|---|---|---|
| Price | $64.73 | $78.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 14 |
| Target Price | ★ $93.60 | $76.50 |
| AVG Volume (30 Days) | 602.7K | ★ 1.1M |
| Earning Date | 01-28-2026 | 02-24-2026 |
| Dividend Yield | ★ 2.26% | N/A |
| EPS Growth | N/A | ★ 30.70 |
| EPS | 2.62 | ★ 3.17 |
| Revenue | $1,349,130,000.00 | ★ $12,938,000,000.00 |
| Revenue This Year | $5.03 | $5.35 |
| Revenue Next Year | $4.02 | $3.34 |
| P/E Ratio | ★ $24.37 | $24.79 |
| Revenue Growth | ★ 5.92 | 3.51 |
| 52 Week Low | $63.23 | $60.56 |
| 52 Week High | $89.66 | $82.49 |
| Indicator | DLB | HSIC |
|---|---|---|
| Relative Strength Index (RSI) | 42.02 | 67.00 |
| Support Level | $63.23 | $75.31 |
| Resistance Level | $66.34 | $76.95 |
| Average True Range (ATR) | 1.04 | 1.30 |
| MACD | -0.25 | -0.06 |
| Stochastic Oscillator | 34.33 | 80.63 |
Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.